NT5E and melanoma: Despite these data and there being a significant increase in expression with disease stage, CD73 score was not found to be an independent prognostic factor in melanoma [96]; however, clinical data from NSCLC patients revealed CD73 as an independent indicator of poor prognosis in overall survival in those harboring EGFR or ALK mutations [97,98].